{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T21:52:11Z","timestamp":1753739531989,"version":"3.37.3"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T00:00:00Z","timestamp":1690329600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammopharmacol"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s10787-023-01299-6","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T10:01:33Z","timestamp":1690365693000},"page":"2383-2392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Methotrexate is associated with decreased total thyroxine in patients with rheumatoid arthritis"],"prefix":"10.1007","volume":"31","author":[{"given":"Shu-Lin","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8510-6127","authenticated-orcid":false,"given":"Qiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang-Song","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,26]]},"reference":[{"issue":"9","key":"1299_CR1","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1299_CR2","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.jss.2013.05.089","volume":"185","author":"A Alhefdhi","year":"2013","unstructured":"Alhefdhi A, Burke JF, Redlich A et al (2013) Leflunomide suppresses growth in human medullary thyroid cancer cells. J Surg Res 185(1):212\u2013216. https:\/\/doi.org\/10.1016\/j.jss.2013.05.089","journal-title":"J Surg Res"},{"issue":"1","key":"1299_CR3","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1080\/08916930701620100","volume":"41","author":"F Atzeni","year":"2008","unstructured":"Atzeni F, Doria A, Ghirardello A et al (2008) Anti-thyroid antibodies and thyroid dysfunction in rheumatoid arthritis: prevalence and clinical value. Autoimmunity 41(1):111\u2013115. https:\/\/doi.org\/10.1080\/08916930701620100","journal-title":"Autoimmunity"},{"issue":"2","key":"1299_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1001\/jama.2019.9052","volume":"322","author":"B Biondi","year":"2019","unstructured":"Biondi B, Cappola AR, Cooper DS (2019) Subclinical hypothyroidism: a review. JAMA 322(2):153\u2013160. https:\/\/doi.org\/10.1001\/jama.2019.9052","journal-title":"JAMA"},{"key":"1299_CR5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.3389\/fendo.2017.00179","volume":"8","author":"S Bliddal","year":"2017","unstructured":"Bliddal S, Borresen SW, Feldt-Rasmussen U (2017) Thyroid autoimmunity and function after treatment with biological antirheumatic agents in rheumatoid arthritis. Front Endocrinol (Lausanne) 8:179. https:\/\/doi.org\/10.3389\/fendo.2017.00179","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"Suppl 1","key":"1299_CR6","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1007\/s10067-008-1046-2","volume":"28","author":"CA Ca\u00f1as","year":"2009","unstructured":"Ca\u00f1as CA, Tob\u00f3n GJ, Arango LG et al (2009) Developing of granulomatous thyroiditis during etanercept therapy. Clin Rheumatol 28(Suppl 1):S17\u2013S19. https:\/\/doi.org\/10.1007\/s10067-008-1046-2","journal-title":"Clin Rheumatol"},{"key":"1299_CR7","doi-asserted-by":"publisher","first-page":"e4216","DOI":"10.7717\/peerj.4216","volume":"6","author":"YL Chen","year":"2018","unstructured":"Chen YL, Lin JZ, Mo YQ et al (2018) Joint damage is amplified in rheumatoid arthritis patients with positive thyroid autoantibodies. PeerJ 6:e4216. https:\/\/doi.org\/10.7717\/peerj.4216","journal-title":"PeerJ"},{"key":"1299_CR8","doi-asserted-by":"publisher","DOI":"10.1136\/jcp-2022-208290","author":"SN Dwivedi","year":"2022","unstructured":"Dwivedi SN, Kalaria T, Buch H (2022) Thyroid autoantibodies. J Clin Pathol. https:\/\/doi.org\/10.1136\/jcp-2022-208290","journal-title":"J Clin Pathol"},{"issue":"7","key":"1299_CR9","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1002\/art.41752","volume":"73","author":"L Fraenkel","year":"2021","unstructured":"Fraenkel L, Bathon JM, England BR et al (2021) 2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol 73(7):1108\u20131123. https:\/\/doi.org\/10.1002\/art.41752","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"1299_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40265-018-1045-9","volume":"79","author":"N Genere","year":"2019","unstructured":"Genere N, Stan MN (2019) Current and emerging treatment strategies for Graves\u2019 orbitopathy. Drugs 79(2):109\u2013124. https:\/\/doi.org\/10.1007\/s40265-018-1045-9","journal-title":"Drugs"},{"issue":"5","key":"1299_CR11","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1515\/CCLM.2011.144","volume":"49","author":"A Georges","year":"2011","unstructured":"Georges A, Charri\u00e9 A, Raynaud S et al (2011) Thyroxin overdose due to rheumatoid factor interferences in thyroid-stimulating hormone assays. Clin Chem Lab Med 49(5):873\u2013875. https:\/\/doi.org\/10.1515\/CCLM.2011.144","journal-title":"Clin Chem Lab Med"},{"issue":"39","key":"1299_CR12","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1556\/650.2017.30796","volume":"158","author":"Z Hella","year":"2017","unstructured":"Hella Z, Hodinka L, Turbucz P et al (2017) Etanercept-induced subacute thyroiditis. Case report and literature review. Orv Hetil 158(39):1550\u20131554. https:\/\/doi.org\/10.1556\/650.2017.30796","journal-title":"Orv Hetil"},{"key":"1299_CR13","doi-asserted-by":"publisher","first-page":"992883","DOI":"10.3389\/fendo.2022.992883","volume":"13","author":"L Jing","year":"2022","unstructured":"Jing L, Zhang Q (2022) Intrathyroidal feedforward and feedback network regulating thyroid hormone synthesis and secretion. Front Endocrinol (Lausanne) 13:992883. https:\/\/doi.org\/10.3389\/fendo.2022.992883","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"1299_CR14","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1507\/endocrj.48.717","volume":"48","author":"K Kasono","year":"2001","unstructured":"Kasono K, Hikino H, Fujino S et al (2001) Cross-reactive mechanism for the false elevation of free triiodothyronine in the patients treated with diclofenac. Endocr J 48(6):717\u2013722. https:\/\/doi.org\/10.1507\/endocrj.48.717","journal-title":"Endocr J"},{"issue":"15","key":"1299_CR15","doi-asserted-by":"publisher","first-page":"2548","DOI":"10.1093\/hmg\/ddac052","volume":"31","author":"AD Kjaergaard","year":"2022","unstructured":"Kjaergaard AD, Teumer A, Marouli E et al (2022) Thyroid function, pernicious anemia and erythropoiesis: a two-sample Mendelian randomization study. Hum Mol Genet 31(15):2548\u20132559. https:\/\/doi.org\/10.1093\/hmg\/ddac052","journal-title":"Hum Mol Genet"},{"issue":"7","key":"1299_CR18","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1038\/s41584-022-00793-5","volume":"18","author":"N Komatsu","year":"2022","unstructured":"Komatsu N, Takayanagi H (2022) Mechanisms of joint destruction in rheumatoid arthritis - immune cell-fibroblast-bone interactions. Nat Rev Rheumatol 18(7):415\u2013429. https:\/\/doi.org\/10.1038\/s41584-022-00793-5","journal-title":"Nat Rev Rheumatol"},{"key":"1299_CR16","doi-asserted-by":"publisher","first-page":"1015516","DOI":"10.3389\/fendo.2022.1015516","volume":"13","author":"YJ Liu","year":"2022","unstructured":"Liu YJ, Miao HB, Lin S et al (2022) Association between rheumatoid arthritis and thyroid dysfunction: a meta-analysis and systematic review. Front Endocrinol (Lausanne) 13:1015516. https:\/\/doi.org\/10.3389\/fendo.2022.1015516","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1299_CR17","doi-asserted-by":"publisher","first-page":"940633","DOI":"10.3389\/fendo.2022.940633","volume":"13","author":"Y Liu","year":"2022","unstructured":"Liu Y, Li Z, Yang T et al (2022) Impaired sensitivity to thyroid hormones and carotid plaque in patients with coronary heart disease: a RCSCD-TCM study in China. Front Endocrinol (Lausanne) 13:940633. https:\/\/doi.org\/10.3389\/fendo.2022.940633","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"2","key":"1299_CR19","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3899\/jrheum.100488","volume":"38","author":"HG Raterman","year":"2011","unstructured":"Raterman HG, Jamnitski A, Lems WF et al (2011) Improvement of thyroid function in hypothyroid patients with rheumatoid arthritis after 6 months of adalimumab treatment: a pilot study. J Rheumatol 38(2):247\u2013251. https:\/\/doi.org\/10.3899\/jrheum.100488","journal-title":"J Rheumatol"},{"issue":"2","key":"1299_CR20","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1210\/jcem-43-2-338","volume":"43","author":"RN Re","year":"1976","unstructured":"Re RN, Kourides IA, Ridgway EC et al (1976) The effect of glucocorticoid administration on human pituitary secretion of thyrotropin and prolactin. J Clin Endocrinol Metab 43(2):338\u2013346. https:\/\/doi.org\/10.1210\/jcem-43-2-338","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"1299_CR21","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.etap.2005.12.004","volume":"22","author":"G Selmano\u011flu","year":"2006","unstructured":"Selmano\u011flu G, Ko\u00e7kaya EA, Akay MT et al (2006) Subacute toxicity of celecoxib on thyroid and testis of rats: hormonal and histopathological changes. Environ Toxicol Pharmacol 22(1):85\u201389. https:\/\/doi.org\/10.1016\/j.etap.2005.12.004","journal-title":"Environ Toxicol Pharmacol"},{"issue":"6","key":"1299_CR22","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1111\/cen.13834","volume":"89","author":"Z Sipkova","year":"2018","unstructured":"Sipkova Z, Insull EA, David J et al (2018) Early use of steroid-sparing agents in the inactivation of moderate-to-severe active thyroid eye disease: a step-down approach. Clin Endocrinol (Oxf) 89(6):834\u2013839. https:\/\/doi.org\/10.1111\/cen.13834","journal-title":"Clin Endocrinol (Oxf)"},{"key":"1299_CR23","doi-asserted-by":"publisher","first-page":"6895146","DOI":"10.1155\/2018\/6895146","volume":"2018","author":"T Siriwardhane","year":"2018","unstructured":"Siriwardhane T, Krishna K, Ranganathan V et al (2018) Exploring systemic autoimmunity in thyroid disease subjects. J Immunol Res 2018:6895146. https:\/\/doi.org\/10.1155\/2018\/6895146","journal-title":"J Immunol Res"},{"issue":"2","key":"1299_CR24","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/s41433-018-0315-9","volume":"33","author":"D Strianese","year":"2019","unstructured":"Strianese D, Rossi F (2019) Interruption of autoimmunity for thyroid eye disease: B-cell and T-cell strategy. Eye (Lond) 33(2):191\u2013199. https:\/\/doi.org\/10.1038\/s41433-018-0315-9","journal-title":"Eye (Lond)"},{"issue":"12","key":"1299_CR25","doi-asserted-by":"publisher","first-page":"e220303","DOI":"10.1530\/EC-22-0303","volume":"11","author":"J Supronik","year":"2022","unstructured":"Supronik J, Szelachowska M, Kretowski A et al (2022) Rituximab in the treatment of Graves\u2019 orbitopathy: latest updates and perspectives. Endocr Connect 11(12):e220303. https:\/\/doi.org\/10.1530\/EC-22-0303","journal-title":"Endocr Connect"},{"issue":"5","key":"1299_CR26","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1159\/000507826","volume":"10","author":"M Tokumaru","year":"2021","unstructured":"Tokumaru M, Ohba K, Kakudo K et al (2021) Importance of imaging procedures in the evaluation of methotrexate-associated lymphoproliferative disorder of the thyroid gland: a case study. Eur Thyroid J 10(5):434\u2013436. https:\/\/doi.org\/10.1159\/000507826","journal-title":"Eur Thyroid J"},{"issue":"6","key":"1299_CR27","doi-asserted-by":"publisher","first-page":"e183567","DOI":"10.1001\/jamanetworkopen.2018.3567","volume":"1","author":"K Waldenlind","year":"2018","unstructured":"Waldenlind K, Saevarsdottir S, Bengtsson C et al (2018) Risk of thyroxine-treated autoimmune thyroid disease associated with disease onset in patients with rheumatoid arthritis. JAMA Netw Open 1(6):e183567. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.3567","journal-title":"JAMA Netw Open"},{"issue":"2","key":"1299_CR28","doi-asserted-by":"publisher","first-page":"e001282","DOI":"10.1136\/rmdopen-2020-001282","volume":"6","author":"K Waldenlind","year":"2020","unstructured":"Waldenlind K, Delcoigne B, Saevarsdottir S et al (2020) Does autoimmune thyroid disease affect rheumatoid arthritis disease activity or response to methotrexate? RMD Open 6(2):e001282. https:\/\/doi.org\/10.1136\/rmdopen-2020-001282","journal-title":"RMD Open"},{"key":"1299_CR29","doi-asserted-by":"publisher","first-page":"105791","DOI":"10.1016\/j.intimp.2019.105791","volume":"76","author":"J Wang","year":"2019","unstructured":"Wang J, Li R, Lin H et al (2019) Accumulation of cytosolic dsDNA contributes to fibroblast-like synoviocytes-mediated rheumatoid arthritis synovial inflammation. Int Immunopharmacol. 76:105791. https:\/\/doi.org\/10.1016\/j.intimp.2019.105791","journal-title":"Int Immunopharmacol."},{"key":"1299_CR30","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jad.2023.02.068","volume":"328","author":"Q Wang","year":"2023","unstructured":"Wang Q, Xu X, Ren H et al (2023) Prevalence and risk factors of thyroid dysfunction in outpatients with overweight or obese first-episode and drug-na\u00efve major depressive disorder. J Affect Disord 328:135\u2013140. https:\/\/doi.org\/10.1016\/j.jad.2023.02.068","journal-title":"J Affect Disord"}],"container-title":["Inflammopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01299-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10787-023-01299-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10787-023-01299-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T01:14:08Z","timestamp":1695604448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10787-023-01299-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,26]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["1299"],"URL":"https:\/\/doi.org\/10.1007\/s10787-023-01299-6","relation":{},"ISSN":["0925-4692","1568-5608"],"issn-type":[{"type":"print","value":"0925-4692"},{"type":"electronic","value":"1568-5608"}],"subject":[],"published":{"date-parts":[[2023,7,26]]},"assertion":[{"value":"11 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study does not involve identifiable personal information and meets the criteria of exempting patients\u2019 informed consent from the Ethics Committee of the First Affiliated Hospital of Guangzhou University of Chinese Medicine (FAHGUCM). The commitment to protect the privacy of subjects has been submitted to the Ethics Committee. This study has been approved by the Ethics Committee of FAHGUCM (NO. JY [2021]063).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}